The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...
Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...
The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...
A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.
PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...
The changes coming with the new year — including a lower cap on out-of-pocket prescription-drug costs and a new program designed to help enrollees spread out their medication costs over the ...
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...
That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...
If you’re living with diabetes, learn why you may be at greater risk for opioid use (and misuse) and what to do about it.
Three cities in Hawaii, Minnesota, and Texas report the highest usage of injectable weight loss medications. Meanwhile, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback